Allergic rhinitis: the eligible candidate to mite immunotherapy in the real world

As standard drug treatment of allergic rhinitis (AR) is not completely satisfactory, allergen immunotherapy (AIT) represents the only current treatment with the potential to modify the natural history. House dust mite (HDM) allergy is very common. The aim of the current experience was to describe th...

Descripción completa

Detalles Bibliográficos
Autores principales: Ciprandi, Giorgio, Natoli, Valentina, Puccinelli, Paola, Incorvaia, Cristoforo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320802/
https://www.ncbi.nlm.nih.gov/pubmed/28239397
http://dx.doi.org/10.1186/s13223-017-0185-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320802/
https://www.ncbi.nlm.nih.gov/pubmed/28239397
http://dx.doi.org/10.1186/s13223-017-0185-x

Ejemplares similares